Table 9.
Studies without the inclusion criteria.
| Reference | Change CoQ10 Total | Measured Parameters and Effects of CoQ10 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Tissue | Plasma Pre ➝ Post (μg/mL) |
Plasma Pre ➝ Post (μmol/mol Chol) |
Muscle Pre ➝ Post (nmol/g Protein) |
Inflammatory Pattern | Antioxidant Pattern |
Physical Performance | Sport Performance | Muscle Injury | Other | |
| Okudan et al. (2017) | Plasma ↑ | 1.0 ➝ 1.7 | MDA, SOD ↔ | CK, Myogb. ↔ | ||||||
| Östman et al. (2012) | - | MDA, UA, hypoxanthine ↔ | Exercise capacity, VO2max, Max power, Lactate ↔ | CK, UA ↔ | ||||||
| Porter et al. (1995) | Plasma ↑ | 0.7 ➝ 1.0 | VO2max ↔ LA ↓(NS) | Vigor perception ↑ | ||||||
| Snider et al. (1992) | - | Time to exhaustion, RPE ↔ |
||||||||
| Tauler et al. (2008) Ferrer et al. (2009) | Plasma ↑ | 3.0 ➝ 3.6 | SOD ↑, MDA ↓ | ↑ Time spend in active working zone (Z3-Z5) | ||||||
| Vanfraechem et al. (1981) | - | Maximal load and O2 consumption 170 w and max. | Cardiaovascular and cardiorespiratory parameters ↑ | |||||||
| Wyss et al. (1990) | Plasma ↑ | Ns | VO2max ↑, Max work ↑, | |||||||
| Yamabe et al. (1991) | - | VO2max, Max power and Anaerobic threshold ↑ | ||||||||
| Ylikoski et al. (1997) | Plasma ↑ | 0.8 ➝ 2.8 | VO2max, max power, Anaerobic threshold, and HRTime↑ | |||||||
| Zeppilli et al. (1991) | Plasma ↑ | 0.6 ➝ 1.3 Vb 0.7 ➝ 1.0 NA | VO2max, max power ↑ | |||||||
| Zheng et al. (2008) | - | VCO2/VO2 ↓, HR ↔ | ↑ Power HR variability | |||||||
| Zhou et al. (2005) | Plasma↑, Muscle ↔ | 0.8 ➝ 2.6 | 207 ➝ 220 (nmol/g protein) |
VO2max ↔, HR ↔, RPE ↔, Anaerobic threshold ↔ | ||||||
| Zuliani et al. (1989) | Plasma ↑ | 0.5 ➝ 1.3 | Glucose, Insulin, LA ↔ | CK ↔, | Glycerol ↔, FFA ↓ | |||||
| Sanchez-Cuesta et al. (2020) | Plasma ↑ | Preseason 0.6 Middle season 0.9 | The highest values have better competition parameters | CK ↓ | Better Testosterone/cortisol pattern | |||||
CoQ10/Chol: CoQ10 in relation to cholesterol level; pre/post: previous and post supplementation; Ns: No specified; Phys. Physical; Perf: Performance; ↔ similar response to placebo or previous supplementation, ↑ Higher response to the presupplementation phase, ↓ Lower response to the presupplementation phase, NS: Non statistical significance. The study of Sanchez-Cuesta as it is explained in the text, is the follow up of the CQ10 plasma level throughout 2 competition seasons. Vb volleyball, NA No physical activity, HR heart rate, RPE rating perceived perception.